Prudential Financial’s Vera Therapeutics VERA Stock Holding History

Prudential Financial’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$832K	Buy	+20,690	New	+$891K	﹤0.01%	1663
2025 Q3	–	Sell	-62,037	Closed	-$1.46M	–	2534
2025 Q2	$1.46M	Sell	62,037 -21,540	-26%	-$484K	﹤0.01%	1514
2025 Q1	$2.01M	Buy	83,577 +500	+0.6%	+$16.1K	﹤0.01%	1285
2024 Q4	$3.51M	Buy	83,077 +20,880	+34%	+$924K	﹤0.01%	1009
2024 Q3	$2.75M	Buy	62,197 +13,085	+27%	+$497K	﹤0.01%	1294
2024 Q2	$1.78M	Buy	+49,112	New	+$1.95M	﹤0.01%	1498

Other funds holding VERA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Prudential Financial's VERA Position: Q1 2026 in Review

Prudential Financial opened a new position in Vera Therapeutics (VERA) in Q1 2026: 20,690 shares worth $832K. The stake represents ﹤0.01% of the portfolio and ranks #1663 among its holdings. This is a return to the name: Prudential Financial previously reported a position in VERA as recently as Q2 2025.

Prudential Financial first reported a position in VERA in Q2 2024 and has held it in 6 quarters since. The position peaked at $3.51M in Q4 2024. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

Prudential Financial held 20,690 shares of Vera Therapeutics worth $832K as of Q1 2026.
Vera Therapeutics was a new Prudential Financial position in Q1 2026.
Vera Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1663 holding.
Prudential Financial first reported a position in Vera Therapeutics in Q2 2024 and has held it in 6 quarters since.
Prudential Financial's Vera Therapeutics position peaked at $3.51M in Q4 2024.
229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.